Zynerba Pharmaceuticals, Inc.
http://zynerba.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Zynerba Pharmaceuticals, Inc.
Beacon Eye Gene Therapy Efforts Buoyed By Cash Boost
In a major boost for the UK biotech sector, an impressive sum has been raised by Beacon Therapeutics to support its R&D activities in ophthalmic gene therapies.
€80m Cash Boost Helps iOnctura Accelerate Eye Cancer Candidate
The proceeds from the impressive series B financing will help progress roginolisib through Phase II trials.
Two Better Than One As Syncona Creates Spur
The merger of Freeline and SwanBio is establishing an entity with secure financing to advance their respective gene therapies for Gaucher’s disease and adrenomyeloneuropathy.
Deal Watch: Leo Pharma Adds Rare Dermatology Disorder Candidate In Timber Buyout
Plus deals involving SK Biopharmaceuticals, Hikma and Proteovant, Day One/Sprint, Eyenovia/Formosa, Clinigen/CNX, Ikena/Pionyr and more.
Company Information
- Industry
-
Pharmaceuticals
-
Drug Delivery
- Transdermal
-
Drug Delivery
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice